Organization: MaRS Innovation

CQDM and Ontario partners launch funding program

The Quebec Consortium for Drug Discovery (CQDM) and three Ontario organizations are launching the Quebec/Ontario CQDM Funding Program to support collaborative research projects and develop new tools for biopharmaceutical research. The program is seen as the first tangible realization of the emerging Ontario-Quebec Life Sciences Corridor, which was announced last year and accelerated with two…

MaRS and J&J to support early-stage technologies

MaRS Innovation has teamed with Johnson & Johnson Corporate Office of Science and Technology to launch a co-managed and co-financed fund for early-stage development of Toronto-based life sciences technologies. Each party will commit a defined capital pool to support high-potential projects identified by a joint management committee. The objective is to take a technology to…

MaRS Innovation to commercialize two technologies

MaRS Innovation has announced its first two medical technologies for commercialization. MaRS Innovation — funded through the Centres of Excellence for Commercialization and Research program (R$, October 7/08) — is collaborating with the Samuel Lunenfeld Research Institute (SLRI) to commercialize an umbilical cord stem cell technology to initially treat diabetes and possible cardiovascular disease and…